YAA Medics: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
YAA Medics
Largest movements
- Cash -€26,375
down €26,375 (-31.5%), from €83,855 to €57,480
mainly Net result for the year (-€28,501) and Investment in fixed assets (net) (-€2,435)
- Tangible fixed assets -€4,685
down €4,685 (-26.2%), from €17,863 to €13,178
of which Furniture and vehicles: -€4,095
- Profit (loss) carried forward -€28,500
down €28,500 (-24.8%), from €114,752 to €86,252
- Trade debts -€2,292
down €2,292 (-46.6%), from €4,916 to €2,624
- Gross operating margin -€71,140
down €71,140, from €45,562 to -€25,578
- Taxes -€12,689
down €12,689, from €7,854 to -€4,835
- Depreciation -€7,889
down €7,889 (-54.3%), from €14,522 to €6,633
- Staff costs -€2,403
no longer reported in 2025 (was €2,403)
- Other operating charges +€598
up €598 (+55.6%), from €1,075 to €1,673
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €124,668 | €94,040 | -€30,628 | -24.6% |
| Fixed assets | 21/28 | €17,863 | €13,665 | -€4,198 | -23.5% |
| Tangible fixed assets | 22/27 | €17,863 | €13,178 | -€4,685 | -26.2% |
| Plant, machinery and equipment | 23 | €1,428 | €838 | -€590 | -41.3% |
| Furniture and vehicles | 24 | €16,435 | €12,340 | -€4,095 | -24.9% |
| Financial fixed assets | 28 | - | €487 | +€487 | |
| Current assets | 29/58 | €106,805 | €80,375 | -€26,430 | -24.7% |
| Amounts receivable within one year | 40/41 | €22,950 | €22,814 | -€136 | -0.6% |
| Other amounts receivable | 41 | €22,950 | €22,814 | -€136 | -0.6% |
| Cash at bank and in hand | 54/58 | €83,855 | €57,480 | -€26,375 | -31.5% |
| Deferred charges and accrued income | 490/1 | - | €82 | +€82 | |
| Total equity and liabilities | 10/49 | €124,668 | €94,040 | -€30,628 | -24.6% |
| Equity | 10/15 | €119,752 | €91,252 | -€28,500 | -23.8% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €114,752 | €86,252 | -€28,500 | -24.8% |
| Amounts payable | 17/49 | €4,916 | €2,789 | -€2,127 | -43.3% |
| Amounts payable within one year | 42/48 | €4,916 | €2,789 | -€2,127 | -43.3% |
| Trade debts | 44 | €4,916 | €2,624 | -€2,292 | -46.6% |
| Suppliers | 440/4 | €4,916 | €2,624 | -€2,292 | -46.6% |
| Taxes, remuneration and social security | 45 | - | €165 | +€165 | |
| Taxes | 450/3 | - | €165 | +€165 | |
| Remuneration, social security and pensions | 62 | €2,403 | - | -€2,403 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €14,522 | €6,633 | -€7,889 | -54.3% |
| Other operating charges | 640/8 | €1,075 | €1,673 | +€598 | +55.6% |
| Gross operating margin | 9900 | €45,562 | -€25,578 | -€71,140 | |
| Operating profit (loss) | 9901 | €27,562 | -€33,884 | -€61,446 | |
| Financial income | 75/76B | €668 | €803 | +€135 | +20.1% |
| Recurring financial income | 75 | €668 | €803 | +€135 | +20.1% |
| Financial charges | 65/66B | €449 | €254 | -€195 | -43.4% |
| Recurring financial charges | 65 | €449 | €254 | -€195 | -43.4% |
| Profit (loss) for the period before taxes | 9903 | €27,781 | -€33,336 | -€61,117 | |
| Income taxes | 67/77 | €7,854 | -€4,835 | -€12,689 | |
| Profit (loss) for the period | 9904 | €19,927 | -€28,501 | -€48,428 | |
| Profit (loss) for the period to be appropriated | 9905 | €19,927 | -€28,501 | -€48,428 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.